Company intelligence / Profile preview

EndoCellutions

Marshfield, Massachusetts, United Statesendocellutions.com ↗

Ownership: Private
Development stage: Commercial

Overview

EndoCellutions has developed a point-of-care device that efficiently prepares concentrated viable cells from bone marrow aspirate and platelet-rich plasma. The system offers high yields, consistent separation, intuitive operation compatible with standard centrifuges, and competitive performance advantages. It supports clinicians in delivering autologous regenerative therapies at the bedside. No direct clinical trial results are reported; the product appears to be commercially available.

Therapeutic areas: OtherRheumatology
Modalities: Device-based cell processingDevice
Industry: Therapeutic Medical Devices

Beyond the preview

Go deeper on EndoCellutions.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on EndoCellutions.

Explore the full profile